Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis

Journal of Rheumatology

Volumn 33, Issue 1, 2006, Pages 74-78

  Gonzalez Juanatey, Carlos ^a   Llorca, Javier ^b   Garcia Porrua, Carlos ^a   Sanchez Andrade, Amalia ^a   Martín, Javier ^c   Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Endothelial dysfunction; Flow mediated endothelial dependent vasodilatation; Giant cell arteritis; Temporal artery biopsy

Indexed keywords

GLYCERYL TRINITRATE; METHYLPREDNISOLONE; PREDNISONE; STEROID;

AGED; ARTERY ENDOTHELIUM; ARTICLE; BIOPSY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; GIANT CELL ARTERITIS; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; STEROID THERAPY; VASODILATATION;

AGED; AGED, 80 AND OVER; BIOPSY; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOCORTICOIDS; HUMANS; LONGITUDINAL STUDIES; MALE; METHYLPREDNISOLONE; REGIONAL BLOOD FLOW; TEMPORAL ARTERITIS; VASODILATION;

EID: 30144438165     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-49.
2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
3. Lie JT and the Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
5. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
6. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002;105:1567-72.
7. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002;1:338-47.
8. Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996;94:2103-6.
9. Raza K, Thambyrajah J, Townend JN, et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 2000;102:1470-2.
10. Filer AD, Gardner-Medwin JM, Thambyrajah J, et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003;62:162-7.
11. Bacon PA. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol 2005;17:49-55.
12. Gonzalez-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
13. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
14. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine Baltimore 2000;79:283-92.
15. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy-proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750-5.
16. Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-53.
17. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, et al. HLA-DRB1 status influences endothelial dysfunction in long-term treated patients with rheumatoid arthritis. Am J Med 2003;114:647-52.
18. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Gonzalez-Gay MA. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor-α antibody. Arthritis Rheum 2004;51:447-50.
19. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002;46:1489-97.
20. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine Baltimore 2003;82:407-13.
21. Wallberg-Jonsson S, Ohman M, Rantapaa-Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? Scand J Rheumatol 2004;33:373-9.
22. Eller NH, Netterstrom B, Allerup P. Progression in intima media thickness - the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology 2005;30:715-23.
23. Hurwitz Eller N, Netterstrom B, Hansen AM. Cortisol in urine and saliva: relations to the intima media thickness, IMT. Atherosclerosis 2001;159:175-85.
24. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549-50.
25. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa-Dahlqvist S. Increased mortality due to cardiovascular disease in GCA in Northern Sweden. J Rheumatol 2002;29:737-42.
26. Gonzalez-Gay MA, Rubiera G, Piñeiro A, et al. Ischémic heart disease in patients from northwest Spain with biopsy proven giant cell arteritis. A population based study. J Rheumatol 2005;32:502-6.
27. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
28. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981;209:337-45.
29. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.
30. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A, Pego-Reigosa A, Llorca J, Hunder GG. Aortic aneurysm and dissection in biopsy-proven giant cell arteritis patients from Northwest Spain. A population-based study. Medicine (Baltimore) 2004;83:335-41.